Peripheral catecholamine enzyme function and cognitive impairment of elderly schizophrenics and controls

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Catecholamine system alterations are implicated in schizophrenia and dementia.
• Peripheral enzyme activities may reflect central nervous system changes.

Purpose of the Study:

• To investigate the relationship between peripheral catecholamine enzyme activities and cognitive function in elderly schizophrenic patients and controls.
• To identify specific enzyme activity patterns associated with cognitive impairment and dementia in this population.

Main Methods:

• Bivariate and multivariate statistical analyses were employed.
• Peripheral enzyme activities, including platelet monoamine oxidase (MAO) and plasma dopamine beta-hydroxylase (DBH), were measured.
• Cognitive function was assessed in elderly schizophrenic patients and age/gender-matched controls.

Main Results:

• A significant inverse relationship was observed between platelet monoamine oxidase (MAO) activity and cognitive impairment across the entire sample, even after controlling for age, race, and gender.
• Schizophrenic subjects exhibited an inverse relationship between plasma dopamine beta-hydroxylase (DBH) activity and cognitive impairment.
• Demented subjects, in both schizophrenic and control groups, showed elevated platelet MAO activity.
• Demented schizophrenic subjects additionally presented with increased plasma DBH activity.

Conclusions:

• Peripheral catecholamine enzyme activities, specifically MAO and DBH, are associated with cognitive function in elderly individuals, particularly those with schizophrenia.
• Elevated MAO and DBH levels may serve as biomarkers for dementia in schizophrenic populations.
• Further research is warranted to elucidate the complex interplay between catecholamine systems, cognitive decline, and schizophrenia.